SYMBYX is an Australian medical technology company developing innovative laser light therapies to treat previously intractable, chronic diseases. Our main focus is helping people manage their Parkinson’s symptoms by treating their gut. There is an already wide and growing body of evidence linking the gut in a Parkinson’s disease model (this is called the Gut-Brain-Axis).
Light therapy or photobiomodulation (PMBt) is not a new area of medicine. There are currently over 4,000 peer-reviewed studies reporting on its safe, protective and restorative properties for a number of health problems. What is new, however, is that a study involving SYMBYX’s CE marked/ARTG listed laser devices and proprietary treatment protocols was published on 2 July 2021 in BMC Neurology for delivering sustained improvements in clinical signs of Parkinson’s disease. Symptomatic relief varies from individual to individual as Parkinson’s affects everyone differently. In our trials, patients have reported wide ranging motor improvements, better sleep, lightened mood, reduced muscle pain and even returned sense of smell. To learn more, please check out our website www.symbyxbiome.com.